Ligand Pharmaceuticals
LGND
LGND
265 hedge funds and large institutions have $2.97B invested in Ligand Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 110 increasing their positions, 90 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 251 → 265 (+14)
50% less call options, than puts
Call options by funds: $6.02M | Put options by funds: $12M
Holders
265
Holding in Top 10
14
Calls
$6.02M
Puts
$12M
Top Buyers
| 1 | +$34.9M | |
| 2 | +$20.9M | |
| 3 | +$20M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$18.7M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$17.9M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$20.4M | |
| 3 | -$15.7M | |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$15.5M |
| 5 |
Bank of New York Mellon
New York
|
-$12M |